pharma news

News

Activist investor renews its criticism of Novavax

Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."

News

Jeito's founder and president, Dr Rafaèle Tordjman

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

US judge blocks bid to curb abortion pill access

A bid to limit access to the abortion pill mifepristone in the US, while the FDA carries out a review of the drug, has been blocked in the courts.

News

Gilead strikes again, penning $5bn deal to buy Tubulis

Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.

News

Kennedy changes vaccine panel charter after legal setback

A change to the ACIP charter has raised concerns of even greater political influence over the vaccine panel by HHS Secretary Kennedy.

Activist investor renews its criticism of Novavax

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

EU invests €30m to fight antimicrobial resistance

US judge blocks bid to curb abortion pill access

Gilead strikes again, penning $5bn deal to buy Tubulis

Kennedy changes vaccine panel charter after legal setback

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks